These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28830659)

  • 21. The role of diet in prevention and management of type 2 diabetes: implications for public health.
    Lazarou C; Panagiotakos D; Matalas AL
    Crit Rev Food Sci Nutr; 2012; 52(5):382-9. PubMed ID: 22369258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].
    Nadal JF; Gutiérrez PC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():7-13. PubMed ID: 24444518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
    Lamanna C; Monami M; Marchionni N; Mannucci E
    Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyslipidemia in youth with diabetes: to treat or not to treat?
    Maahs DM; Wadwa RP; Bishop F; Daniels SR; Rewers M; Klingensmith GJ
    J Pediatr; 2008 Oct; 153(4):458-65. PubMed ID: 18847618
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
    [No Abstract]   [Full Text] [Related]  

  • 26. Mediterranean diet and type 2 diabetes.
    Esposito K; Giugliano D
    Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():34-40. PubMed ID: 24357346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
    [No Abstract]   [Full Text] [Related]  

  • 28. [Reduction of cardiovascular risk--a new approach in therapy of type 2 diabetes].
    Standl E
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():1. PubMed ID: 14694833
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical trial of the month. The STENO-2 study: a plea for global and intensive management of the type 2 diabetic patient].
    Scheen AJ; Estrella F
    Rev Med Liege; 2003 Feb; 58(2):109-11. PubMed ID: 12693313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes mellitus and cardiovascular risk: Update of the recommendations of the Diabetes and Cardiovascular Disease working group of the Spanish Diabetes Society (SED, 2018).
    Arrieta F; Iglesias P; Pedro-Botet J; Becerra A; Ortega E; Obaya JC; Nubiola A; Maldonado GF; Campos MDM; Petrecca R; Pardo JL; Sánchez-Margalet V; Alemán JJ; Navarro J; Duran S; Tébar FJ; Aguilar M; Escobar F;
    Clin Investig Arterioscler; 2018; 30(3):137-153. PubMed ID: 29754804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arterial risk in type 2 diabetes: from mega-trials to prescription].
    Bonnet F; Moulin P
    Rev Prat; 2003 May; 53(10):1095-101. PubMed ID: 12846030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis.
    Chen L; Pei JH; Kuang J; Chen HM; Chen Z; Li ZW; Yang HZ
    Metabolism; 2015 Feb; 64(2):338-47. PubMed ID: 25467842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpharmacologic treatment of dyslipidemia.
    Houston MC; Fazio S; Chilton FH; Wise DE; Jones KB; Barringer TA; Bramlet DA
    Prog Cardiovasc Dis; 2009; 52(2):61-94. PubMed ID: 19732602
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the long-term effects of high-fat v. low-fat diet consumption on cardiometabolic risk factors in subjects with abnormal glucose metabolism: a systematic review and meta-analysis.
    Schwingshackl L; Hoffmann G
    Br J Nutr; 2014 Jun; 111(12):2047-58. PubMed ID: 24666665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective randomized controlled trial of lifestyle intervention on quality of life and cardiovascular risk score in patients with obesity and type 2 diabetes.
    Tuthill A; Quinn A; McColgan D; McKenna M; O'Shea D; McKenna TJ
    Diabetes Obes Metab; 2007 Nov; 9(6):917-9. PubMed ID: 17451423
    [No Abstract]   [Full Text] [Related]  

  • 37. [Positive influence on cardiovascular risk factor by blocking the endocannabinoid system].
    Chatterjee T; Ritz A; Ince H; Nienaber ChA; Rehders TC
    Praxis (Bern 1994); 2008 May; 97(11):613-21. PubMed ID: 18592956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of use and potential impact of increased use of primary care interventions to prevent cardiovascular hospitalizations in patients with diabetes.
    Luft VC; Giugliani C; Harzheim E; Schmidt MI; Duncan BB
    Diabetes Res Clin Pract; 2009 Sep; 85(3):328-34. PubMed ID: 19625099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should you put all diabetic patients on statins?
    Leiter LA
    J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention and management of cardiovascular disease in patients with diabetes mellitus: an evidence base.
    Yudkin JS; Blauth C; Drury P; Fuller J; Henley J; Lancaster T; Lankester J; Lean M; Pentecost B; Press V; Rothman D
    Diabet Med; 1996 Sep; 13(9 Suppl 4):S101-21. PubMed ID: 8894461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.